Teva Pharmaceutical Industries Ltd
TEVA30.330USD
+0.010+0.03%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
34.80BMarket Cap
48.75P/E TTM
More Details of Teva Pharmaceutical Industries Ltd Company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd Info
Ticker SymbolTEVA
Company nameTeva Pharmaceutical Industries Ltd
IPO dateFeb 06, 2087
CEOFrancis (Richard D)
Number of employees33892
Security typeDepository Receipt
Fiscal year-endFeb 06
Address124 Dvora Hanevi'a St.
CityTEL AVIV-YAFO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryIsrael
Postal code6944020
Phone97239148213
Websitehttps://www.tevapharm.com/
Ticker SymbolTEVA
IPO dateFeb 06, 2087
CEOFrancis (Richard D)
Company Executives of Teva Pharmaceutical Industries Ltd
Name
Name/Position
Position
Shareholding
Change
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
Other
501.00M
12.00%
By RegionUSD
Name
Revenue
Proportion
United States
2.15B
51.51%
Europe
1.30B
31.06%
International Markets
495.00M
11.85%
Other
232.00M
5.56%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
Other
501.00M
12.00%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
Other
83.84%
Shareholders
Shareholders
Proportion
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
Other
83.84%
Shareholder Types
Shareholders
Proportion
Investment Advisor
22.99%
Investment Advisor/Hedge Fund
12.47%
Hedge Fund
10.45%
Insurance Company
6.24%
Research Firm
2.35%
Pension Fund
1.69%
Family Office
1.47%
Bank and Trust
0.90%
Sovereign Wealth Fund
0.24%
Other
41.19%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Phoenix Investment and Finances Ltd
37.76M
3.29%
+10.30M
+37.49%
Jun 30, 2025
Menora Mivtachim Insurance Ltd.
57.40M
5%
+18.90M
+49.10%
Jul 16, 2025
Harel Insurance Investments and Financial Services Ltd
33.39M
2.91%
+11.33M
+51.39%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
33.89M
2.95%
+833.03K
+2.52%
Jun 30, 2025
Migdal Insurance and Financial Holdings Ltd
28.69M
2.5%
+2.35M
+8.92%
Jun 30, 2025
Clal Insurance Enterprises Holdings Ltd.
32.36M
2.82%
-5.43M
-14.37%
Jun 30, 2025
Lingotto Investment Management LLP
28.16M
2.45%
+302.98K
+1.09%
Jun 30, 2025
Rubric Capital Management LP
26.00M
2.27%
+450.00K
+1.76%
Jun 30, 2025
PointState Capital LP
20.71M
1.81%
+5.58M
+36.88%
Jun 30, 2025
Fidelity Management & Research Company LLC
50.63M
4.41%
-24.67M
-32.76%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares MSCI Israel ETF
7.76%
VanEck Israel ETF
7.5%
VanEck Pharmaceutical ETF
3.79%
First Trust WCM Developing World Equity ETF
3.16%
First Trust WCM International Equity ETF
2.64%
ARK Israel Innovative Technology ETF
1.81%
WealthTrust DBS Long Term Growth ETF
1.42%
WisdomTree International Multifactor Fund
0.77%
iShares Health Innovation Active ETF
0.69%
iShares MSCI Intl Value Factor ETF
0.46%
View more
iShares MSCI Israel ETF
Proportion7.76%
VanEck Israel ETF
Proportion7.5%
VanEck Pharmaceutical ETF
Proportion3.79%
First Trust WCM Developing World Equity ETF
Proportion3.16%
First Trust WCM International Equity ETF
Proportion2.64%
ARK Israel Innovative Technology ETF
Proportion1.81%
WealthTrust DBS Long Term Growth ETF
Proportion1.42%
WisdomTree International Multifactor Fund
Proportion0.77%
iShares Health Innovation Active ETF
Proportion0.69%
iShares MSCI Intl Value Factor ETF
Proportion0.46%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Teva Pharmaceutical Industries Ltd?
The top five shareholders of Teva Pharmaceutical Industries Ltd are:
Phoenix Investment and Finances Ltd holds 37.76M shares, accounting for 3.29% of the total shares.
Menora Mivtachim Insurance Ltd. holds 57.40M shares, accounting for 5.00% of the total shares.
Harel Insurance Investments and Financial Services Ltd holds 33.39M shares, accounting for 2.91% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 33.89M shares, accounting for 2.95% of the total shares.
Migdal Insurance and Financial Holdings Ltd holds 28.69M shares, accounting for 2.50% of the total shares.
Phoenix Investment and Finances Ltd holds 37.76M shares, accounting for 3.29% of the total shares.
Menora Mivtachim Insurance Ltd. holds 57.40M shares, accounting for 5.00% of the total shares.
Harel Insurance Investments and Financial Services Ltd holds 33.39M shares, accounting for 2.91% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 33.89M shares, accounting for 2.95% of the total shares.
Migdal Insurance and Financial Holdings Ltd holds 28.69M shares, accounting for 2.50% of the total shares.
What are the top three shareholder types of Teva Pharmaceutical Industries Ltd?
The top three shareholder types of Teva Pharmaceutical Industries Ltd are:
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
How many institutions hold shares of Teva Pharmaceutical Industries Ltd (TEVA)?
As of 2025Q3, 1124 institutions hold shares of Teva Pharmaceutical Industries Ltd, with a combined market value of approximately 742.23M, accounting for 64.70% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -0.61%.
What is the biggest source of revenue for Teva Pharmaceutical Industries Ltd?
In FY2025Q2, the Generic products business generated the highest revenue for Teva Pharmaceutical Industries Ltd, amounting to 2.41B and accounting for 57.73% of total revenue.
